Montreal, March 30, 2017 – NEOMED-LABS, a Canadian specialty company providing customized and high-throughput immune-monitoring for clinical vaccine and biologics development, announced today that their laboratories have been granted the Good Clinical Laboratory Practices (GCLP) Accreditation by Qualogy Ltd.
“This is an important milestone for our growing organization to be provided an independent assessment of clinical laboratory operations through the Qualogy accreditation scheme”, said Dr. Luc Vachon, President and CEO of NEOMED-LABS.
NEOMED-LABS supports clinical Phase I to IV vaccine development programs of multinational pharma companies, Biotechs and non-for profit organizations. This accreditation demonstrates that NEOMED-LABS operates according to high standards, which comply with the recognized GCLP requirements.
